US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT06134375 Phase 1, Phase 2
Recruiting
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
Condition
Triple Negative Breast Cancer
Enrollment
204 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT04638647 Phase 4
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
Condition
Autoimmunity, Inflammation
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05882058 Phase 2
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With...
Condition
Small Cell Lung Carcinoma
Enrollment
204 pts
Location
United States, Belgium, Bulgaria
Sponsor
Boehringer Ingelheim
View Trial →
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
View Trial →
NCT06379789 Phase 1, Phase 2
Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX G...
Condition
Hemophilia B
Enrollment
130 pts
Location
United States, Australia, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04920617 Phase 2
Recruiting
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosp...
Condition
Relapsed Diffuse Large B-cell Lymphoma
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
ImmunoVaccine Technologies, In
View Trial →
NCT04443088 Phase 1
Recruiting
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembro...
Condition
Cancer
Enrollment
78 pts
Location
United States
Sponsor
Shenzhen Ionova Life Sciences
View Trial →
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06740630 Phase 3
Recruiting
A Study on the Immune Response and Safety of an Investigational Chickenpox Vacci...
Condition
Chickenpox
Enrollment
1,840 pts
Location
United States, Belgium, Colombia
Sponsor
GlaxoSmithKline
View Trial →
NCT05677971 Phase 3
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People ...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
160 pts
Location
United States, Australia, Austria
Sponsor
Takeda
View Trial →
NCT05837663 N/A
Recruiting
Trifecta-Lung cfDNA-MMDx Study
Condition
Lung Transplantation
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
University of Alberta
View Trial →
NCT07010887 N/A
Recruiting
RHI Interval Effects on Brain Health
Condition
Repetitive Head Impacts
Enrollment
102 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06247787 Phase 1
Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine a...
Condition
Recurrent Childhood Acute Myeloid Leukemia
Enrollment
36 pts
Location
United States
Sponsor
Children's Oncology Group
View Trial →
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
View Trial →
NCT03266640 Phase 2
Recruiting
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CM...
Condition
Cytomegalovirus Infections
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
View Trial →
NCT06413979 N/A
Recruiting
Family Support Protocol for Adolescent Internalizing Disorders
Condition
Internalizing Disorders
Enrollment
60 pts
Location
United States
Sponsor
The National Center on Addicti
View Trial →
NCT07269210 Phase 2
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceride...
Condition
Severe Hypertriglyceridemia
Enrollment
60 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
View Trial →
NCT07725523 Phase 2, Phase 3
Recruiting
Safety and Efficacy of OTL78
Condition
Prostate Cancer Surgery
Enrollment
45 pts
Location
United States
Sponsor
Clinton Bahler
View Trial →
NCT07339423 Phase 3
Recruiting
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...
Condition
Obesity
Enrollment
1,150 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
View Trial →
NCT07152717 N/A
Recruiting
Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compres...
Condition
Venous Leg Ulcers (VLUs)
Enrollment
40 pts
Location
United States
Sponsor
Feeltect Limited
View Trial →
NCT06935591 N/A
Recruiting
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Dr...
Condition
Atrial Fibrillation (AF)
Enrollment
423 pts
Location
United States, Germany
Sponsor
Vektor Medical
View Trial →
NCT06425848 N/A
Recruiting
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Condition
Heart Failure
Enrollment
2,000 pts
Location
United States
Sponsor
University of Kansas Medical C
View Trial →
Page 2 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology